title: [Diffuse Lewy body disease].
abstract: Diffuse Lewy body disease is the second cause of dementia after Alzheimer's disease. It is characterized by a progressive dementia, often difficult to differentiate from Alzheimer's disease, but fluctuations of cognitive deficits, frequent hallucinations, delirium, hypersensitivity to neuroleptics, unexplained falls, atypical receiving "black-outs" and parkinsonian features are characteristics features evocative of the diagnosis. The response to anticholinesterase medication is often much better than in Alzheimer's disease.
authors.affiliation: Service de neurologie, CHUV, BH 13, 1011 Lausanne.
authors.forename: J
authors.initials: J
authors.lastname: Ghika
mesh_terms: D001706:Biopsy; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003937:Diagnosis, Differential; D018450:Disease Progression; D006801:Humans; D020961:Lewy Body Disease / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology; D015995:Prevalence; D016896:Treatment Outcome
chemical_list: D002800:Cholinesterase Inhibitors